Dr. Christopher J. Oldfield, M.D.
Family Medicine (Family Medicine Physician)
- Medicare participating
At a glance
- Medical school
- Medical College of Georgia School of Medicine (1997)
- Years since graduation
- 29
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 889
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1997Medical school: Medical College of Georgia School of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Family Medicine Physician primary
GA license 046195
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Candler Hospital Savannah, GA
- St Joseph's Hospital - Savannah Savannah, GA
- Liberty Regional Medical Center Hinesville, GA
Medical groups
- Privia Medical Group of Georgia LLC (462 clinicians)
- Curana Health Medical Group LLC (138 clinicians)
- Ch Specialty Services Ga LLC (30 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 889
- Services billed
- 25,291
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | 873 | 241 |
| Insertion of needle into vein for collection of blood sample | 557 | 334 |
| Established patient office or other outpatient visit, 30-39 minutes | 511 | 274 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 480 | 298 |
| Automated urinalysis test | 451 | 299 |
| Blood test, comprehensive group of blood chemicals | 423 | 263 |
| Blood test, lipids (cholesterol and triglycerides) | 408 | 251 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 382 | 382 |
| Ldl cholesterol level | 374 | 232 |
| Annual depression screening, 5 to 15 minutes | 279 | 279 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in Savannah, GA | 2,871 |
| Amlodipine Besylate Other prescribers in Savannah, GA | 2,500 |
| Furosemide Other prescribers in Savannah, GA | 1,553 |
| Levothyroxine Sodium Other prescribers in Savannah, GA | 1,413 |
| Gabapentin Other prescribers in Savannah, GA | 1,361 |
| Divalproex Sodium Other prescribers in Savannah, GA | 1,172 |
| Trazodone Hcl Other prescribers in Savannah, GA | 1,131 |
| Potassium Chloride Other prescribers in Savannah, GA | 1,094 |
| Eliquis (apixaban) Other prescribers in Savannah, GA | 999 |
| Carvedilol Other prescribers in Savannah, GA | 984 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 22 companies reported 80 payments worth $1,374 in total to this clinician.
| Amgen Inc. | $232 |
|---|---|
| Novo Nordisk Inc | $224 |
| AstraZeneca Pharmaceuticals LP | $139 |
| AbbVie Inc. | $114 |
| Lilly USA, LLC | $113 |
| Pfizer Inc. | $91.81 |
| Novartis Pharmaceuticals Corporation | $89.15 |
| GlaxoSmithKline, LLC. | $53.18 |
| Food and Beverage | $1,374 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 6 industry-funded studies in 2025, from 5 companies. The companies reported $903,428 in research payments for these studies, mostly to the institutions running them.
- A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age
ModernaTX, Inc. · Completed · NCT06602024 - A master protocol to investigate the efficacy and safety of orforglipron tablet once daily compared with placebo in participants with obesity or overweight with and without type 2 diabetes: J2A-mc-GZP1, J2A-mc-GZP2
Eli Lilly and Company - A phase 3,global,randomized,modified double blind,placebo controlled,study to evaluate the efficacy,immunogenicity,and safety of IVX A12,a respiratory syncytial virus RSV and human metapneumovirus hMPV virus like part…
AstraZeneca Pharmaceuticals LP - Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness
Vanda Pharmaceuticals Inc. - A master protocol to investigate the efficacy and safety of orforglipron tablet once daily compared with placebo in participants with obesity or overweight with and without type 2 diabetes: J2A-mc-GZP1, J2A-mc-GZP2
Eli Lilly Export S.a. Puerto Rico Branch - A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
Eli Lilly and Company · Active, not recruiting · NCT06972472
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.